Dr. Trang Hoang, recipient of the Jeanne Manery Fisher Memorial Lecture Award
The award recognizes eminent Canadian woman scientist who has a distinguished career in the fields of biochemistry, molecular or cellular biology or genetics, resulting from outstanding contributions.
Trang Hoang, principal investigator at the Institute for Research in Immunology and Cancer (IRIC) and a professor in the Department of Pharmacology of the Faculty of Medicine of Université de Montréal, is the recipient of the Canadian Society for Molecular Biosciences (CSMB)’s Jeanne Manery Fisher Memorial Lecture Award.
The award is given in honour of the late Jeanne Manery Fisher, professor of biochemistry at the University of Toronto. Dr. Fisher was not only an outstanding biochemist, but a remarkable teacher. She was instrumental in creating the Society’s equal-opportunity committee and fought diligently for the position of women in science.
“Dr. Hoang epitomizes the values of excellence in research and teaching, of service to the broader community and of equity and diversity”, said Marc Therrien, IRIC’s scientific director.
In 2019, Trang Hoang was named an officer of the Ordre national du Québec and a commander Ordre de Montréal for her pivotal work in acute lymphoblastic leukemia and for developing and nurturing multidisciplinary skills in cancer research to train the next generation of scientists.
Throughout her distinguished career, she has been a remarkable role model for young women and men aspiring to a career in the life sciences. She has trained over 72 students and postdoctoral fellows who later held leadership positions in academia, in biotech companies and in funding agencies. As a mentor, she has fostered creativity in women and encouraged them to pursue careers in research.
Recognized for her expertise at the forefront of normal and leukemic stem-cell biology, Dr. Hoang has also served on Canadian and international grant review panels, as well as advisory boards of the Fonds de recherche du Québec – Santé and of the Leukemia and Lymphoma Society of Canada. Her current research involves quantitative analysis of chemical-genetic interactions in mammalian cells, using high throughput functional assays for the systematic identification of pre-leukemic stem cell vulnerabilities.